Patent · US Active

Expression of chimeric KSAC protein and method of producing soluble proteins by high pressure

US10364274B2 · kind B2 · utility

0Cited by
10References
10Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 5, 2016
Grant dateJul 30, 2019
Priority date
Expiry dateMay 8, 2036

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention encompasses vaccines or compositions comprising the chimeric KSAC protein that possesses immunogenic and protective properties, and methods of use including administering to an animal the antigenic KSAC protein thereof to protect animals. The invention also encompasses methods for making and producing the soluble, disaggregated, refolded or active proteins from inclusion bodies produced from prokaryotes or eukaryotes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.